98 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
into US$ at the average rate of the corresponding year; excludes reimbursement of reasonable expenses incurred in the proper conduct of the services
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
”.
Expense Reimbursement
The Arrangement Agreement requires that the Company reimburse the Parent for reasonable documented out-of-pocket third party … Reimbursement”.
Shareholder Approval
To be effective, the Arrangement Resolution must be approved by (i) not less than two-thirds of the votes cast
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
markets (including size) for our product candidates;
our expectations regarding coverage, reimbursement and pricing and acceptance of our product … fee of $75 million. If the acquisition is not approved by shareholders, the Company will pay expense reimbursement for reasonable, documented out
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
, by wire transfer of immediately available funds to an account designated by Parent, expense reimbursement for reasonable, documented out-of-pocket third … or the reimbursement of ordinary course expenses). Other than in the ordinary course or as set forth in Section 11 of the Company Disclosure Schedule
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
” in this Circular. This amount is paid in CDN$, converted into US$ at the average rate of the corresponding year; excludes reimbursement of reasonable expenses
6-K
EX-99.1
8nyejq mb2s73c7
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
qofnop1ymwr
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
oirlt4c4sllz582iqft
14 Nov 22
Supplemental materials (foreign)
5:25pm
F-10
pjk06l7h3hk3 bzw2k
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.2
6hg077 z8ircvz3
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
SUPPL
c742m7d3hd 8rmd
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
kfzcje6zzds0f
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
kk3y99bpsnpc13c
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
8z0etzxfs0 fsdd8
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.2
xllw7xhb1oarfj5268r
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
j5q9460d1o6
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.1
gwkno outle
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.2
y8nwb0c1oeatukkz4
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.3
wcnecvj 2u
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
d7u6px
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm